Gene insertion and long-term expression in lung mediated by the Sleeping Beauty transposon system
- PMID: 12946324
- DOI: 10.1016/s1525-0016(03)00211-9
Gene insertion and long-term expression in lung mediated by the Sleeping Beauty transposon system
Abstract
Gene transfer to the lung could provide important new treatments for chronic and acquired lung diseases such as cystic fibrosis, alpha1-antitrypsin deficiency, emphysema, and cancer. DNA-mediated gene transfer to the lung has been previously demonstrated, but anticipated effectiveness has been limited by low gene transfer efficiencies and by transient expression of the transgene. Here, we combine plasmid-based gene transfer with the integrating capacity of the nonviral Sleeping Beauty (SB) transposon vector system to mediate gene insertion and long-term gene expression in mouse lung. We observed transgene expression after 24 h in lungs of all animals injected with the luciferase transposon (pT/L), but expression for up to 3 months required codelivery of a plasmid encoding the Sleeping Beauty transposase. We also observed long-term expression in pT/L-injected animals transgenic for SB transposase. Transgene expression was localized to the alveolar region of the lung, with transfection including mainly type II pneumocytes. We used a linker-mediated PCR technique to recover transposon flanking sequences, demonstrating transposition of pT/L into mouse chromosomal DNA of the lung.
Similar articles
-
Helper-Independent Sleeping Beauty transposon-transposase vectors for efficient nonviral gene delivery and persistent gene expression in vivo.Mol Ther. 2003 Oct;8(4):654-65. doi: 10.1016/s1525-0016(03)00216-8. Mol Ther. 2003. PMID: 14529839
-
Counterselection and co-delivery of transposon and transposase functions for Sleeping Beauty-mediated transposition in cultured mammalian cells.Biosci Rep. 2004 Dec;24(6):577-94. doi: 10.1007/s10540-005-2793-9. Biosci Rep. 2004. PMID: 16158196
-
Integration and long-term expression in xenografted human glioblastoma cells using a plasmid-based transposon system.Mol Ther. 2004 Aug;10(2):260-8. doi: 10.1016/j.ymthe.2004.05.005. Mol Ther. 2004. PMID: 15294173
-
Sleeping beauty transposon-mediated gene therapy for prolonged expression.Adv Genet. 2005;54:189-232. doi: 10.1016/S0065-2660(05)54009-4. Adv Genet. 2005. PMID: 16096013 Review.
-
Sleeping beauty transposition: biology and applications for molecular therapy.Mol Ther. 2004 Feb;9(2):147-56. doi: 10.1016/j.ymthe.2003.11.009. Mol Ther. 2004. PMID: 14759798 Review.
Cited by
-
Sleeping Beauty transposon-mediated engineering of human primary T cells for therapy of CD19+ lymphoid malignancies.Mol Ther. 2008 Mar;16(3):580-9. doi: 10.1038/sj.mt.6300404. Epub 2008 Jan 29. Mol Ther. 2008. PMID: 18227839 Free PMC article.
-
Mouse models of cancer: Sleeping Beauty transposons for insertional mutagenesis screens and reverse genetic studies.Semin Cell Dev Biol. 2014 Mar;27:86-95. doi: 10.1016/j.semcdb.2014.01.006. Epub 2014 Jan 24. Semin Cell Dev Biol. 2014. PMID: 24468652 Free PMC article. Review.
-
Somatic integration of an oncogene-harboring Sleeping Beauty transposon models liver tumor development in the mouse.Proc Natl Acad Sci U S A. 2005 Nov 22;102(47):17059-64. doi: 10.1073/pnas.0502974102. Epub 2005 Nov 14. Proc Natl Acad Sci U S A. 2005. PMID: 16286660 Free PMC article.
-
A novel method for somatic transgenesis of the mouse prostate using the Sleeping Beauty transposon system.Prostate. 2014 May;74(7):781-91. doi: 10.1002/pros.22797. Epub 2014 Mar 20. Prostate. 2014. PMID: 24647932 Free PMC article.
-
Novel therapeutic approaches for various cancer types using a modified sleeping beauty-based gene delivery system.PLoS One. 2014 Jan 21;9(1):e86324. doi: 10.1371/journal.pone.0086324. eCollection 2014. PLoS One. 2014. PMID: 24466025 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical